OSE Immunotherapeutics SA Appoints Dr. Frédérique Corallo, as Chief Medical Officer, Immunology
November 28, 2016 at 10:15 pm IST
OSE Immunotherapeutics SA announced the appointment of Dr. Frédérique Corallo to the position of Chief Medical Officer, Immunology, further strengthening the company’s scientific and medical expertise within this therapeutic area. Dr. Corallo will lead the development of OSE Immunotherapeutics’s innovative products, with a particular emphasis on autoimmune diseases. Dr. Corallo is a physician, specializing in immunology, and has over 25 years of global experience in the pharmaceutical and biotechnology industries. Prior to joining OSE Immunotherapeutics, she spent over 10 years as Medical Director at Biogen.